{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:14:26Z","timestamp":1792131266010,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472169"],"award-info":[{"award-number":["82472169"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010229","name":"Natural Science Foundation of Tianjin Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["22JCZXJC00170"],"award-info":[{"award-number":["22JCZXJC00170"]}],"id":[{"id":"10.13039\/501100010229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04265-x","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T16:05:01Z","timestamp":1742313901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Extracellular vesicles derived from mesenchymal stem cells alleviate renal fibrosis via the miR-99b-5p\/mTOR\/autophagy axis in diabetic kidney disease"],"prefix":"10.1186","volume":"16","author":[{"given":"Rongrong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoniao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4603-3743","authenticated-orcid":false,"given":"Zongjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"issue":"4","key":"4265_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.mcna.2023.03.004","volume":"107","author":"S Gupta","year":"2023","unstructured":"Gupta S, Dominguez M, Golestaneh L. Diabetic kidney disease: an update. Med Clin North Am. 2023;107(4):689\u2013705. https:\/\/doi.org\/10.1016\/j.mcna.2023.03.004.","journal-title":"Med Clin North Am"},{"issue":"7","key":"4265_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41589-023-01528-7","volume":"20","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Sun T, Yu F, Liu W, Gao J, Chen J, et al. PAFAH2 suppresses synchronized ferroptosis to ameliorate acute kidney injury. Nat Chem Biol. 2024;20(7):835\u201346. https:\/\/doi.org\/10.1038\/s41589-023-01528-7.","journal-title":"Nat Chem Biol"},{"issue":"3","key":"4265_CR3","doi-asserted-by":"publisher","first-page":"e2204626","DOI":"10.1002\/advs.202204626","volume":"10","author":"K Zhang","year":"2023","unstructured":"Zhang K, Li R, Chen X, Yan H, Li H, Zhao X, et al. Renal endothelial Cell-Targeted extracellular vesicles protect the kidney from ischemic injury. Adv Sci (Weinh). 2023;10(3):e2204626. https:\/\/doi.org\/10.1002\/advs.202204626.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"4265_CR4","doi-asserted-by":"publisher","first-page":"15018","DOI":"10.1038\/nrdp.2015.18","volume":"1","author":"MC Thomas","year":"2015","unstructured":"Thomas MC, Brownlee M, Susztak K, Sharma K, Jandeleit-Dahm KAM, Zoungas S, et al. Diabetic kidney disease. Nat Reviews Disease Primers. 2015;1(1):15018. https:\/\/doi.org\/10.1038\/nrdp.2015.18.","journal-title":"Nat Reviews Disease Primers"},{"issue":"12","key":"4265_CR5","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/s41581-021-00474-8","volume":"17","author":"S Avraham","year":"2021","unstructured":"Avraham S, Korin B, Chung J-J, Oxburgh L, Shaw AS. The mesangial cell \u2014 the glomerular stromal cell. Nat Rev Nephrol. 2021;17(12):855\u201364. https:\/\/doi.org\/10.1038\/s41581-021-00474-8.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"4265_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12964-024-01502-3","volume":"22","author":"S Hu","year":"2024","unstructured":"Hu S, Hang X, Wei Y, Wang H, Zhang L, Zhao L. Crosstalk among podocytes, glomerular endothelial cells and mesangial cells in diabetic kidney disease: an updated review. Cell Commun Signal. 2024;22(1):136. https:\/\/doi.org\/10.1186\/s12964-024-01502-3.","journal-title":"Cell Commun Signal"},{"key":"4265_CR7","doi-asserted-by":"publisher","first-page":"115025","DOI":"10.1016\/j.biopha.2023.115025","volume":"165","author":"W Guo","year":"2023","unstructured":"Guo W, Li H, Li Y, Kong W. Renal intrinsic cells remodeling in diabetic kidney disease and the regulatory effects of SGLT2 inhibitors. Biomed Pharmacother. 2023;165:115025. https:\/\/doi.org\/10.1016\/j.biopha.2023.115025.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"4265_CR8","doi-asserted-by":"publisher","first-page":"12133","DOI":"10.1021\/acsnano.0c05681","volume":"14","author":"C Zhang","year":"2020","unstructured":"Zhang C, Shang Y, Chen X, Midgley AC, Wang Z, Zhu D, et al. Supramolecular nanofibers containing Arginine-Glycine-Aspartate (RGD) peptides boost therapeutic efficacy of extracellular vesicles in kidney repair. ACS Nano. 2020;14(9):12133\u201347. https:\/\/doi.org\/10.1021\/acsnano.0c05681.","journal-title":"ACS Nano"},{"key":"4265_CR9","doi-asserted-by":"publisher","unstructured":"Salemkour Y, Yildiz D, Dionet L, t, Hart DC, Verheijden KAT, Saito R et al. (2023). Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy. J Am Soc Nephrol, 34(11), 1823\u20131842. https:\/\/doi.org\/10.1681\/asn.0000000000000212","DOI":"10.1681\/asn.0000000000000212"},{"issue":"9","key":"4265_CR10","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1172\/jci135536","volume":"130","author":"Z Ma","year":"2020","unstructured":"Ma Z, Li L, Livingston MJ, Zhang D, Mi Q, Zhang M, et al. p53\/microRNA-214\/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease. J Clin Invest. 2020;130(9):5011\u201326. https:\/\/doi.org\/10.1172\/jci135536.","journal-title":"J Clin Invest"},{"issue":"7","key":"4265_CR11","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1080\/15548627.2015.1049799","volume":"11","author":"O Lenoir","year":"2015","unstructured":"Lenoir O, Jasiek M, H\u00e9nique C, Guyonnet L, Hartleben B, Bork T, et al. Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis. Autophagy. 2015;11(7):1130\u201345. https:\/\/doi.org\/10.1080\/15548627.2015.1049799.","journal-title":"Autophagy"},{"issue":"1","key":"4265_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s10020-021-00310-6","volume":"27","author":"K Chen","year":"2021","unstructured":"Chen K, Yu B, Liao J. LncRNA SOX2OT alleviates mesangial cell proliferation and fibrosis in diabetic nephropathy via Akt\/mTOR-mediated autophagy. Mol Med. 2021;27(1):71. https:\/\/doi.org\/10.1186\/s10020-021-00310-6.","journal-title":"Mol Med"},{"issue":"9","key":"4265_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41581-020-0309-2","volume":"16","author":"C Tang","year":"2020","unstructured":"Tang C, Livingston MJ, Liu Z, Dong Z. Autophagy in kidney homeostasis and disease. Nat Rev Nephrol. 2020;16(9):489\u2013508. https:\/\/doi.org\/10.1038\/s41581-020-0309-2.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"4265_CR14","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1080\/0886022x.2018.1489287","volume":"40","author":"L Liu","year":"2018","unstructured":"Liu L, Yang L, Chang B, Zhang J, Guo Y, Yang X. The protective effects of Rapamycin on cell autophagy in the renal tissues of rats with diabetic nephropathy via mTOR-S6K1-LC3II signaling pathway. Ren Fail. 2018;40(1):492\u20137. https:\/\/doi.org\/10.1080\/0886022x.2018.1489287.","journal-title":"Ren Fail"},{"key":"4265_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.omtn.2017.08.011","volume":"9","author":"XY Li","year":"2017","unstructured":"Li XY, Wang SS, Han Z, Han F, Chang YP, Yang Y, et al. Triptolide restores autophagy to alleviate diabetic renal fibrosis through the miR-141-3p\/PTEN\/Akt\/mTOR pathway. Mol Ther Nucleic Acids. 2017;9:48\u201356. https:\/\/doi.org\/10.1016\/j.omtn.2017.08.011.","journal-title":"Mol Ther Nucleic Acids"},{"key":"4265_CR16","doi-asserted-by":"publisher","first-page":"154700","DOI":"10.1016\/j.phymed.2023.154700","volume":"112","author":"R Dong","year":"2023","unstructured":"Dong R, Zhang X, Liu Y, Zhao T, Sun Z, Liu P, et al. Rutin alleviates EndMT by restoring autophagy through inhibiting HDAC1 via PI3K\/AKT\/mTOR pathway in diabetic kidney disease. Phytomedicine. 2023;112:154700. https:\/\/doi.org\/10.1016\/j.phymed.2023.154700.","journal-title":"Phytomedicine"},{"issue":"1","key":"4265_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13287-019-1177-1","volume":"10","author":"J Jin","year":"2019","unstructured":"Jin J, Shi Y, Gong J, Zhao L, Li Y, He Q, et al. Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte. Stem Cell Res Ther. 2019;10(1):95. https:\/\/doi.org\/10.1186\/s13287-019-1177-1.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"4265_CR18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00018-017-2639-1","volume":"75","author":"D Yang","year":"2018","unstructured":"Yang D, Livingston MJ, Liu Z, Dong G, Zhang M, Chen JK, et al. Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential. Cell Mol Life Sci. 2018;75(4):669\u201388. https:\/\/doi.org\/10.1007\/s00018-017-2639-1.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"4265_CR19","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.2337\/db13-1279","volume":"63","author":"MZ Zhang","year":"2014","unstructured":"Zhang MZ, Wang Y, Paueksakon P, Harris RC. Epidermal growth factor receptor Inhibition slows progression of diabetic nephropathy in association with a decrease in Endoplasmic reticulum stress and an increase in autophagy. Diabetes. 2014;63(6):2063\u201372. https:\/\/doi.org\/10.2337\/db13-1279.","journal-title":"Diabetes"},{"issue":"11","key":"4265_CR20","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1681\/asn.2012111080","volume":"24","author":"K Yamahara","year":"2013","unstructured":"Yamahara K, Kume S, Koya D, Tanaka Y, Morita Y, Chin-Kanasaki M, et al. Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions. J Am Soc Nephrol. 2013;24(11):1769\u201381. https:\/\/doi.org\/10.1681\/asn.2012111080.","journal-title":"J Am Soc Nephrol"},{"issue":"03","key":"4265_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1055\/s-0044-1788044","volume":"11","author":"Z Li","year":"2024","unstructured":"Li Z, Han Z, Han Z-C. Mesenchymal stem cells in clinical trials for immune disorders. Global Med Genet. 2024;11(03):196\u20139. https:\/\/doi.org\/10.1055\/s-0044-1788044.","journal-title":"Global Med Genet"},{"key":"4265_CR22","doi-asserted-by":"publisher","first-page":"108760","DOI":"10.1016\/j.pharmthera.2024.108760","volume":"265","author":"K Pan","year":"2025","unstructured":"Pan K, Li Q, Guo Z, Li Z. Healing action of Interleukin-4 (IL-4) in acute and chronic inflammatory conditions: mechanisms and therapeutic strategies. Pharmacol Ther. 2025;265:108760. https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108760.","journal-title":"Pharmacol Ther"},{"issue":"10","key":"4265_CR23","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1161\/circresaha.122.321384","volume":"131","author":"D Zhu","year":"2022","unstructured":"Zhu D, Liu S, Huang K, Wang Z, Hu S, Li J, et al. Intrapericardial exosome therapy dampens cardiac injury via activating Foxo3. Circ Res. 2022;131(10):e135\u201350. https:\/\/doi.org\/10.1161\/circresaha.122.321384.","journal-title":"Circ Res"},{"issue":"2","key":"4265_CR24","doi-asserted-by":"publisher","first-page":"e2403068","DOI":"10.1002\/adhm.202403068","volume":"14","author":"Y Liu","year":"2025","unstructured":"Liu Y, Chen S, Huang HY, Midgley AC, Han ZB, Han ZC, et al. Ligand-Tethered extracellular vesicles mediated RNA therapy for liver fibrosis. Adv Healthc Mater. 2025;14(2):e2403068. https:\/\/doi.org\/10.1002\/adhm.202403068.","journal-title":"Adv Healthc Mater"},{"key":"4265_CR25","doi-asserted-by":"publisher","first-page":"100002","DOI":"10.1016\/j.vesic.2022.100002","volume":"1","author":"KD Popowski","year":"2022","unstructured":"Popowski KD, L\u00f3pez de Juan Abad B, George A, Silkstone D, Belcher E, Chung J, et al. Inhalable exosomes outperform liposomes as mRNA and protein drug carriers to the lung. Extracell Vesicle. 2022;1:100002. https:\/\/doi.org\/10.1016\/j.vesic.2022.100002.","journal-title":"Extracell Vesicle"},{"issue":"3","key":"4265_CR26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/ird3.77","volume":"2","author":"E Fu","year":"2024","unstructured":"Fu E, Li Z. Extracellular vesicles: A new frontier in the theranostics of cardiovascular diseases. iRADIOLOGY. 2024;2(3):240\u201359. https:\/\/doi.org\/10.1002\/ird3.77.","journal-title":"iRADIOLOGY"},{"key":"4265_CR27","doi-asserted-by":"publisher","unstructured":"Li R, Wang C, Chen X, Fu E, Zhang K, Tao H et al. (2024). Phosphatidylserine-mediated uptake of extracellular vesicles by hepatocytes ameliorates liver ischemia-reperfusion injury. Apoptosis, 2025;30:69\u201382. https:\/\/doi.org\/10.1007\/s10495-024-02030-8","DOI":"10.1007\/s10495-024-02030-8"},{"issue":"4","key":"4265_CR28","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/stmcls\/sxad010","volume":"41","author":"Y Wang","year":"2023","unstructured":"Wang Y, Liu J, Wang H, Lv S, Liu Q, Li S, et al. Mesenchymal stem Cell-Derived exosomes ameliorate diabetic kidney disease through the NLRP3 signaling pathway. Stem Cells. 2023;41(4):368\u201383. https:\/\/doi.org\/10.1093\/stmcls\/sxad010.","journal-title":"Stem Cells"},{"issue":"10","key":"4265_CR29","doi-asserted-by":"publisher","first-page":"e22517","DOI":"10.1096\/fj.202200488R","volume":"36","author":"C Cui","year":"2022","unstructured":"Cui C, Zang N, Song J, Guo X, He Q, Hu H, et al. Exosomes derived from mesenchymal stem cells attenuate diabetic kidney disease by inhibiting cell apoptosis and epithelial-to-mesenchymal transition via miR-424-5p. Faseb J. 2022;36(10):e22517. https:\/\/doi.org\/10.1096\/fj.202200488R.","journal-title":"Faseb J"},{"key":"4265_CR30","doi-asserted-by":"publisher","first-page":"e84820","DOI":"10.7554\/eLife.84820","volume":"12","author":"H Huang","year":"2023","unstructured":"Huang H, Qian M, Liu Y, Chen S, Li H, Han Z, et al. Genetically engineered mesenchymal stem cells as a nitric oxide reservoir for acute kidney injury therapy. Elife. 2023;12:e84820. https:\/\/doi.org\/10.7554\/eLife.84820.","journal-title":"Elife"},{"issue":"1","key":"4265_CR31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13287-022-02922-z","volume":"13","author":"A Huang","year":"2022","unstructured":"Huang A, Liu Y, Qi X, Chen S, Huang H, Zhang J, et al. Intravenously transplanted mesenchymal stromal cells: a new endocrine reservoir for cardioprotection. Stem Cell Res Ther. 2022;13(1):253. https:\/\/doi.org\/10.1186\/s13287-022-02922-z.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"4265_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3727\/096368916X692726","volume":"26","author":"L Liang","year":"2017","unstructured":"Liang L, Li Z, Ma T, Han Z, Du W, Geng J, et al. Transplantation of human Placenta-Derived mesenchymal stem cells alleviates critical limb ischemia in diabetic nude rats. Cell Transpl. 2017;26(1):45\u201361. https:\/\/doi.org\/10.3727\/096368916X692726.","journal-title":"Cell Transpl"},{"issue":"18","key":"4265_CR33","doi-asserted-by":"publisher","first-page":"1903746","DOI":"10.1002\/advs.201903746","volume":"7","author":"J Zheng","year":"2020","unstructured":"Zheng J, Lu T, Zhou C, Cai J, Zhang X, Liang J, et al. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells protect liver ischemia\/reperfusion injury by reducing CD154 expression on CD4\u2009+\u2009T cells via CCT2. Adv Sci (Weinh). 2020;7(18):1903746. https:\/\/doi.org\/10.1002\/advs.201903746.","journal-title":"Adv Sci (Weinh)"},{"key":"4265_CR34","doi-asserted-by":"publisher","first-page":"6496","DOI":"10.1038\/ncomms7496","volume":"6","author":"T Madhusudhan","year":"2015","unstructured":"Madhusudhan T, Wang H, Dong W, Ghosh S, Bock F, Thangapandi VR, et al. Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy. Nat Commun. 2015;6:6496. https:\/\/doi.org\/10.1038\/ncomms7496.","journal-title":"Nat Commun"},{"issue":"8","key":"4265_CR35","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1681\/asn.2015060676","volume":"27","author":"K Shahzad","year":"2016","unstructured":"Shahzad K, Bock F, Al-Dabet MM, Gadi I, Kohli S, Nazir S, et al. Caspase-1, but not Caspase-3, promotes diabetic nephropathy. J Am Soc Nephrol. 2016;27(8):2270\u20135. https:\/\/doi.org\/10.1681\/asn.2015060676.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"4265_CR36","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/cjn.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032\u201345. https:\/\/doi.org\/10.2215\/cjn.11491116.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"4265_CR37","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12951-024-02613-2","volume":"22","author":"C Ji","year":"2024","unstructured":"Ji C, Zhang J, Shi H, Chen B, Xu W, Jin J, et al. Single-cell RNA transcriptomic reveal the mechanism of MSC derived small extracellular vesicles against DKD fibrosis. J Nanobiotechnol. 2024;22(1):339. https:\/\/doi.org\/10.1186\/s12951-024-02613-2.","journal-title":"J Nanobiotechnol"},{"key":"4265_CR38","doi-asserted-by":"publisher","first-page":"9575","DOI":"10.2147\/IJN.S459077","volume":"19","author":"L Xia","year":"2024","unstructured":"Xia L, Yang M, Zang N, Song J, Chen J, Hu H, et al. PEGylated beta-Cell-Targeting exosomes from mesenchymal stem cells improve beta cell function and quantity by suppressing NRF2-Mediated ferroptosis. Int J Nanomed. 2024;19:9575\u201396. https:\/\/doi.org\/10.2147\/IJN.S459077.","journal-title":"Int J Nanomed"},{"key":"4265_CR39","doi-asserted-by":"publisher","first-page":"1348043","DOI":"10.3389\/fimmu.2024.1348043","volume":"15","author":"A Banerjee","year":"2024","unstructured":"Banerjee A, Singla DK. MSC exosomes attenuate sterile inflammation and necroptosis associated with TAK1-pJNK-NFKB mediated cardiomyopathy in diabetic ApoE KO mice. Front Immunol. 2024;15:1348043. https:\/\/doi.org\/10.3389\/fimmu.2024.1348043.","journal-title":"Front Immunol"},{"key":"4265_CR40","doi-asserted-by":"publisher","unstructured":"Liu L, Chen Y, Li X, Wang J, Yang L. Therapeutic potential: the role of mesenchymal stem cells from diverse sources and their derived exosomes in diabetic nephropathy. Biomed Pharmacother. 2024;175. https:\/\/doi.org\/10.1016\/j.biopha.2024.116672.","DOI":"10.1016\/j.biopha.2024.116672"},{"issue":"10","key":"4265_CR41","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41581-022-00608-6","volume":"18","author":"N Mahtal","year":"2022","unstructured":"Mahtal N, Lenoir O, Tinel C, Anglicheau D, Tharaux PL. MicroRNAs in kidney injury and disease. Nat Rev Nephrol. 2022;18(10):643\u201362. https:\/\/doi.org\/10.1038\/s41581-022-00608-6.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"4265_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12964-022-00997-y","volume":"21","author":"YC Tsai","year":"2023","unstructured":"Tsai YC, Kuo MC, Hung WW, Wu PH, Chang WA, Wu LY, et al. Proximal tubule-derived exosomes contribute to mesangial cell injury in diabetic nephropathy via miR-92a-1-5p transfer. Cell Commun Signal. 2023;21(1):10. https:\/\/doi.org\/10.1186\/s12964-022-00997-y.","journal-title":"Cell Commun Signal"},{"issue":"8","key":"4265_CR43","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1007\/s12015-023-10606-1","volume":"19","author":"S Ning","year":"2023","unstructured":"Ning S, Chen Y, Li S, Liu M, Liu H, Ye M, et al. Exosomal miR-99b-5p secreted from mesenchymal stem cells can retard the progression of colorectal cancer by targeting FGFR3. Stem Cell Rev Rep. 2023;19(8):2901\u201317. https:\/\/doi.org\/10.1007\/s12015-023-10606-1.","journal-title":"Stem Cell Rev Rep"},{"key":"4265_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1476-4598-12-81","volume":"12","author":"F Wei","year":"2013","unstructured":"Wei F, Liu Y, Guo Y, Xiang A, Wang G, Xue X, et al. miR-99b-targeted mTOR induction contributes to irradiation resistance in pancreatic cancer. Mol Cancer. 2013;12:81. https:\/\/doi.org\/10.1186\/1476-4598-12-81.","journal-title":"Mol Cancer"},{"key":"4265_CR45","doi-asserted-by":"publisher","unstructured":"Juliana Doblas Massaro 1, Matheus Costa CDP, Silva 2 E. Cinthia Caroline Alves 2, Geraldo Aleixo Passos 3, Elza Tiemi Sakamoto-Hojo 4, Wallace Rodrigues de Holanda Miranda 5, Nathalia Joanne Bispo Cezar 2, Diane Meyre Rassi 2, Felipe Crispim 6, Sergio Atala Dib 6, Maria Cristina Foss-Freitas 5, Daniel Guariz Pinheiro 7, Eduardo Ant\u00f4nio Donadi Post-transcriptional markers associated with clinical complications in Type 1 and Type 2 diabetes mellitus. Mol Cell Endocrinol, 15(490), 1\u201314. https:\/\/doi.org\/10.1016\/j.mce.2019.03.008","DOI":"10.1016\/j.mce.2019.03.008"},{"key":"4265_CR46","doi-asserted-by":"publisher","DOI":"10.2174\/011574888x272011231128073104","author":"H Ruan","year":"2024","unstructured":"Ruan H, Shi H, Luan W, Pan S. Bone marrow mesenchymal stem cell-derived Exosomal microRNA- 99b-5p promotes cell growth of high Glucose-treated human umbilical vein endothelial cells by modulating THAP domain containing 2 expression. Curr Stem Cell Res Ther. 2024. https:\/\/doi.org\/10.2174\/011574888x272011231128073104.","journal-title":"Curr Stem Cell Res Ther"},{"key":"4265_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4728645","volume":"2018","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zhao S, Wu D, Liu X, Shi M, Wang Y, et al. MicroRNA-22 promotes renal tubulointerstitial fibrosis by targeting PTEN and suppressing autophagy in diabetic nephropathy. J Diabetes Res. 2018;2018:1\u201311. https:\/\/doi.org\/10.1155\/2018\/4728645.","journal-title":"J Diabetes Res"},{"key":"4265_CR48","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.2147\/dddt.S174058","volume":"12","author":"X Wang","year":"2018","unstructured":"Wang X, Gao Y, Tian N, Zhu Z, Wang T, Xu J, et al. Astragaloside IV represses high glucose-induced mesangial cells activation by enhancing autophagy via SIRT1 deacetylation of NF-\u03baB p65 subunit. Drug Des Devel Ther. 2018;12:2971\u201380. https:\/\/doi.org\/10.2147\/dddt.S174058.","journal-title":"Drug Des Devel Ther"},{"key":"4265_CR49","doi-asserted-by":"publisher","unstructured":"Yasuda-Yamahara M, Kume S, Maegawa H. Roles of mTOR in diabetic kidney disease. Antioxidants. 2021;10(2). https:\/\/doi.org\/10.3390\/antiox10020321.","DOI":"10.3390\/antiox10020321"},{"issue":"5","key":"4265_CR50","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1681\/asn.2005050549","volume":"17","author":"N Lloberas","year":"2006","unstructured":"Lloberas N, Cruzado JM, Franquesa M, Herrero-Fresneda I, Torras J, Alperovich G, et al. Mammalian target of Rapamycin pathway Blockade slows progression of diabetic kidney disease in rats. J Am Soc Nephrol. 2006;17(5):1395\u2013404. https:\/\/doi.org\/10.1681\/asn.2005050549.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"4265_CR51","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.bbrc.2009.04.136","volume":"384","author":"H Mori","year":"2009","unstructured":"Mori H, Inoki K, Masutani K, Wakabayashi Y, Komai K, Nakagawa R, et al. The mTOR pathway is highly activated in diabetic nephropathy and Rapamycin has a strong therapeutic potential. Biochem Biophys Res Commun. 2009;384(4):471\u20135. https:\/\/doi.org\/10.1016\/j.bbrc.2009.04.136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"14","key":"4265_CR52","doi-asserted-by":"publisher","first-page":"e23798","DOI":"10.1096\/fj.202400359R","volume":"38","author":"W Su","year":"2024","unstructured":"Su W, Yin Y, Zhao J, Hu R, Zhang H, Hu J, et al. Exosomes derived from umbilical cord-derived mesenchymal stem cells exposed to diabetic microenvironment enhance M2 macrophage polarization and protect against diabetic nephropathy. Faseb J. 2024;38(14):e23798. https:\/\/doi.org\/10.1096\/fj.202400359R.","journal-title":"Faseb J"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04265-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04265-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04265-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T16:05:04Z","timestamp":1742313904000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04265-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4265"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04265-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee for the Use of Animals of Nankai University approved the experimental protocols for studies of mesenchymal stem cells (MSCs) for kidney injury therapy (project title: Therapeutic effects and mechanisms of mesenchymal stem cells (MSCs) for acute and chronic injury; Approval no. 20210051; Date of approval: May 20, 2021). Human placenta-derived mesenchymal stem cells (hP-MSCs) were purchased from AmCellGene Co. Ltd., Tianjin, China (\n                      \n                      ). AmCellGene Co. Ltd. confirmed that there was initial ethical approval for collection of hP-MSCs, and the donors had signed informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}